Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents : a case report
BACKGROUND: We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestation.
CASE PRESENTATION: A 36-year-old Japanese pregnant woman received tocolytic therapy with ritodrine hydrochloride, magnesium sulfate, nifedipine, and betamethasone from 28 weeks of gestation. She developed respiratory failure. and her chest X-ray showed enlarged pulmonary vascular shadows. At 29 weeks and 1 day of gestation, she was diagnosed with pulmonary edema induced by tocolytic agents. Because respiratory failure worsened 2 days after ritodrine hydrochloride and magnesium sulfate were stopped, NPPV was initiated. Her respiratory status improved and she was weaned off of NPPV after 3 days. She underwent cesarean section because of breech presentation at 30 weeks and 0 days of gestation due to initiation of labor pains.
CONCLUSIONS: NPPV can be safely administered in cases of tocolytic agent-induced pulmonary edema during pregnancy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Journal of medical case reports - 15(2021), 1 vom: 21. März, Seite 126 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Takahashi, Kotaro [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13256-021-02704-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323002218 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323002218 | ||
003 | DE-627 | ||
005 | 20231225183232.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13256-021-02704-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1076.xml |
035 | |a (DE-627)NLM323002218 | ||
035 | |a (NLM)33743806 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Takahashi, Kotaro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents |b a case report |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.05.2021 | ||
500 | |a Date Revised 14.05.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestation | ||
520 | |a CASE PRESENTATION: A 36-year-old Japanese pregnant woman received tocolytic therapy with ritodrine hydrochloride, magnesium sulfate, nifedipine, and betamethasone from 28 weeks of gestation. She developed respiratory failure. and her chest X-ray showed enlarged pulmonary vascular shadows. At 29 weeks and 1 day of gestation, she was diagnosed with pulmonary edema induced by tocolytic agents. Because respiratory failure worsened 2 days after ritodrine hydrochloride and magnesium sulfate were stopped, NPPV was initiated. Her respiratory status improved and she was weaned off of NPPV after 3 days. She underwent cesarean section because of breech presentation at 30 weeks and 0 days of gestation due to initiation of labor pains | ||
520 | |a CONCLUSIONS: NPPV can be safely administered in cases of tocolytic agent-induced pulmonary edema during pregnancy | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Noninvasive ventilation | |
650 | 4 | |a Pregnancy | |
650 | 4 | |a Preterm labor | |
650 | 4 | |a Pulmonary edema | |
650 | 4 | |a Tocolytic agents | |
650 | 7 | |a Tocolytic Agents |2 NLM | |
650 | 7 | |a Ritodrine |2 NLM | |
650 | 7 | |a I0Q6O6740J |2 NLM | |
700 | 1 | |a Nishijima, Koji |e verfasserin |4 aut | |
700 | 1 | |a Yamaguchi, Masayuki |e verfasserin |4 aut | |
700 | 1 | |a Matsumoto, Kensuke |e verfasserin |4 aut | |
700 | 1 | |a Sugai, Shunya |e verfasserin |4 aut | |
700 | 1 | |a Enomoto, Takayuki |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical case reports |d 2007 |g 15(2021), 1 vom: 21. März, Seite 126 |w (DE-627)NLM169450775 |x 1752-1947 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2021 |g number:1 |g day:21 |g month:03 |g pages:126 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13256-021-02704-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2021 |e 1 |b 21 |c 03 |h 126 |